This study is the first to quantify absolute plasma concentrations of LRG1, C9, SERPINA3, GSN, IGHA1, and APOA4 in GBM patients, and to show that their expression levels are significantly different (p < 0.05) from those in healthy controls. This evidence concerns the gene APOA4 and glioblastoma.